Literature DB >> 21468560

Change of telomere length in angiotensin II-induced human glomerular mesangial cell senescence and the protective role of losartan.

Xin Feng1, Lining Wang, Yao Li.   

Abstract

Telomeres are DNA repeats at the ends of linear chromosomes in eukaryotic cells; they form cap-like specialized structures at chromosome ends to protect them from digestion and degradation. With each cell division, somatic cell telomeres progressively wear and shorten, leading to cell senescence. Various environmental factors, such as oxidative stress and inflammation, can accelerate telomere shortening. The renin angiotensin system seems to be the key mechanism involved in aging. Our previous studies demonstrated that treatment of human glomerular mesangial cells (GMCs) with angiotensin II (AngII) caused cell senescence. It is important to understand whether AngII accelerates telomere shortening in GMCs and further promotes aging. Therefore, this study was designed to investigate the change in telomere length in AngII-induced GMC senescence and the role of the AngII receptor antagonist losartan in delaying this process. The cells were synchronized and divided into a normal control group, an AngII group (AngII, 10⁻⁶ mol/l) and an AngII + losartan group (losartan, 10⁻⁵ mol/l), and were then cultured for 72 h. The telomere lengths were analyzed by Southern blot analysis, cell morphology was monitored, the cell cycle and β-galactosidase staining were determined, and the expression of P53 and P21 proteins was assessed by Western blotting. Compared with the control group, the AngII group exhibited a markedly reduced telomere length, cell cycle arrest, enhanced β-galactosidase staining, and elevated expression of P53 and P21. The AngII + losartan group displayed longer telomere lengths, further reduced β-galactosidase staining and decreased P53 and P21 expression compared to the AngII group. This study confirms that AngII induces the shortening of telomere lengths, P53 and P21 expression, cell cycle arrest, and the resulting cell senescence in GMCs. In addition, losartan significantly reduced telomere shortening and cell senescence.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468560     DOI: 10.3892/mmr.2011.436

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

Review 2.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

Review 3.  The roles of senescence and telomere shortening in cardiovascular disease.

Authors:  Frej Fyhrquist; Outi Saijonmaa; Timo Strandberg
Journal:  Nat Rev Cardiol       Date:  2013-03-12       Impact factor: 32.419

Review 4.  Aging and Renal Disease: Old Questions for New Challenges.

Authors:  Yu-Hsiang Chou; Yung-Ming Chen
Journal:  Aging Dis       Date:  2021-04-01       Impact factor: 6.745

5.  Protective effects of endothelial progenitor cell microvesicles on Ang II‑induced rat kidney cell injury.

Authors:  Yanling Song; Zhenbing Bai; Yuanyuan Zhang; Juming Chen; Minghui Chen; Yunbo Zhang; Xiaodian Zhang; Huade Mai; Bingshu Wang; Yunyun Lin; Shenhong Gu
Journal:  Mol Med Rep       Date:  2021-11-05       Impact factor: 2.952

Review 6.  SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients.

Authors:  Jorge Quarleri; M Victoria Delpino
Journal:  Geroscience       Date:  2022-02-14       Impact factor: 7.713

7.  Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis.

Authors:  Adonis Sfera; Carolina Osorio; Carlos M Zapata Martín Del Campo; Shaniah Pereida; Steve Maurer; Jose Campo Maldonado; Zisis Kozlakidis
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

Review 8.  Cellular senescence, senescence-associated secretory phenotype, and chronic kidney disease.

Authors:  Wen-Juan Wang; Guang-Yan Cai; Xiang-Mei Chen
Journal:  Oncotarget       Date:  2017-04-21

Review 9.  Brain Renin-Angiotensin System at the Intersect of Physical and Cognitive Frailty.

Authors:  Caglar Cosarderelioglu; Lolita S Nidadavolu; Claudene J George; Esther S Oh; David A Bennett; Jeremy D Walston; Peter M Abadir
Journal:  Front Neurosci       Date:  2020-09-30       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.